TSND logo

TerrAscend Corp. Stock Price

TSX:TSND Community·CA$395.4m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

TSND Share Price Performance

CA$1.03
0.70 (212.12%)
CA$2.01
Fair Value
CA$1.03
0.70 (212.12%)
48.6% undervalued intrinsic discount
CA$2.01
Fair Value
Price CA$1.03
AnalystHighTarget CA$2.01
AnalystLowTarget CA$1.27
AnalystConsensusTarget CA$1.86

TSND Community Narratives

·
Fair Value CA$2.01 48.6% undervalued intrinsic discount

US Cannabis Legalization And Digital Health Will Unlock Opportunities

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value CA$1.27 18.7% undervalued intrinsic discount

North American Cannabis Will Face Oversupply And Risks Yet Recover

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value CA$1.88 45.1% undervalued intrinsic discount

Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
CA$1.27
18.7% undervalued intrinsic discount
Profit Margin
7.72%
Future PE
17.76x
Price in 2029
CA$1.52

Trending Discussion

Updated Narratives

TSND logo

TSND: Active M&A Agenda And Margin Improvements Will Support Future Profitability

Fair Value: CA$2.01 48.6% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
TSND logo

TSND: New CFO Hire And Share Buyback Will Support Future Upside

Fair Value: CA$1.27 18.7% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
TSND logo

Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry

Fair Value: CA$1.88 45.1% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with mediocre balance sheet.

2 Risks
3 Rewards

TerrAscend Corp. Key Details

US$261.8m

Revenue

US$125.5m

Cost of Revenue

US$136.2m

Gross Profit

US$164.5m

Other Expenses

-US$28.3m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.091
52.04%
-10.81%
245.4%
View Full Analysis

About TSND

Founded
2017
Employees
933
CEO
Ziad Ghanem
WebsiteView website
www.terrascend.com

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries under the Apothecarium brand name. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

Recent TSND News & Updates

Narrative Update Jun 03

TSND: Active M&A Agenda And Margin Improvements Will Support Future Profitability

Analysts have adjusted their TerrAscend price target to CA$2.01 from CA$2.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News TerrAscend reiterated an active M&A agenda, with executives highlighting ongoing discussions for accretive acquisitions and interest in distressed assets in core markets, sourced from the first quarter 2026 results call.
Narrative Update May 07

TSND: Expanded Retail Footprint And Margin Gains Will Support Future Profitability

Analysts have nudged their TerrAscend price target slightly higher to CA$2.00 from CA$2.00, citing updated assumptions around revenue growth, profit margins and a lower future P/E multiple that together support a modestly improved valuation outlook. What's in the News TerrAscend issued earnings guidance for the first quarter of 2026, anticipating net revenue of $65.5 million, compared with $66.1 million in the fourth quarter of 2025 and $64.3 million in the first quarter of 2025 (Key Developments).

Recent updates

No updates